Wistar is a finalist of the STEM Talent Challenge to create a new life science workforce training program to address Pennsylvania industry growth and demand for skilled workers.
They found that EBV uses some of the same proteins as the host cell to express itself, and one of the proteins is already targeted by an existing drug.